at risk for developing type 1 diabetes
Showing 9976 - 10000 of >10,000
Prospective Study on Feto-maternal outcoMe In aNemIc womEn
Active, not recruiting
- Anemia
- +6 more
- iron deficiency, coagulation abnormalities
-
San Giovanni Rotondo, Foggia, Italy
- +1 more
Feb 20, 2023
Macular Edema, Retinal Vein Occlusion Trial in Assiut (Intravitreal injection of Dexamethasone implant)
Recruiting
- Macular Edema
- Retinal Vein Occlusion
- Intravitreal injection of Dexamethasone implant
-
Assiut, EgyptFaculty of medicine
Feb 27, 2022
Ischemic Stroke, Vertebral Artery Stenosis Trial in Beijing (Drug-eluting stenting plus aspirin and clopidogrel or ticagrelor,
Not yet recruiting
- Ischemic Stroke
- Vertebral Artery Stenosis
- Drug-eluting stenting plus aspirin and clopidogrel or ticagrelor
- +2 more
-
Beijing, ChinaXuanwu Hospital, Capital Medical University.
Jun 1, 2023
Myotonic Dystrophy, Congenital Myotonic Dystrophy, Myotonic Dystrophy 1 Trial in Oakland (Patient-entered data)
Recruiting
- Myotonic Dystrophy
- +15 more
- Patient-entered data
-
Oakland, CaliforniaMyotonic Dystrophy Foundation
Oct 31, 2022
Diabetes and Glycosylation in Cervical Spondylosis
Terminated
- Diabetes
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Feb 8, 2021
Type 2 Diabetes, Cardiovascular Diseases Trial in Aachen (Liraglutide Pen Injector [Victoza], Placebo)
Withdrawn
- Type 2 Diabetes
- Cardiovascular Diseases
- Liraglutide Pen Injector [Victoza]
- Placebo
-
Aachen, GermanyDepartment of Internal Medicine I, University Hospital
Mar 9, 2021
Parkinson Disease Trial in Pavia (Telerehabilitation with open source platforms)
Completed
- Parkinson Disease
- Telerehabilitation with open source platforms
-
Pavia, PV, ItalyIcs Maugeri
Mar 8, 2023
Genetic Testing on Patients' Stress Levels
Active, not recruiting
- Breast Cancer
- Questionnaires to Evaluate Anxiety Related to Genetic Testing
-
Milwaukee, WisconsinFroedtert Hospital
Oct 9, 2022
Breast Cancer Trial in Caen, Rouen (Cognitive stimulation)
Active, not recruiting
- Breast Cancer
- Cognitive stimulation
-
Caen, France
- +1 more
Mar 8, 2022
Obesity, Non-Alcoholic Fatty Liver Disease, Insulin Resistance Trial in Amsterdam (Early time restricted eating, Late time
Recruiting
- Obesity
- +2 more
- Early time restricted eating
- Late time restricted eating
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam UMC, location AMC
Sep 24, 2023
Waterpipe Size Trial in Arlington (Waterpipe size)
Recruiting
- Waterpipe Size
- Waterpipe size
-
Arlington, TexasUniversity of Texas at Arlington
Jan 26, 2023
ICU Predictive Score of WEaning Success in Patients At Risk of
Recruiting
- Mechanical Ventilator Weaning
- +12 more
-
Clermont-Ferrand, FranceCHU
Jan 30, 2023
ctDNA and/or HPV DNA in High-risk Locally-advanced Head and Neck
Active, not recruiting
- Cancer
- +2 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 7, 2022
Ventricular Tachycardia, Arrhythmia Trial in Baltimore (123I-metaiodobenzylguanidine)
Completed
- Ventricular Tachycardia
- Arrhythmia
-
Baltimore, MarylandUniversity of Maryland Medical Center, EP Lab, Rm. N3W77
Jan 25, 2022
Insomnia, Anxiety Trial in Hong Kong (CBT-I, CBT-A)
Recruiting
- Insomnia
- Anxiety
- CBT-I
- CBT-A
-
Hong Kong, Hong KongSleep Research Clinic & Laboratory, Department of Psychology, Th
Sep 19, 2023
Prediabetes, Diabetes Type 2, Obesity Trial in Bergholz-Rehbrücke, Berlin (dietary consulting)
Unknown status
- Prediabetes
- +4 more
- dietary consulting
-
Bergholz-Rehbrücke, Brandenburg, Germany
- +1 more
Jun 23, 2020
Chronic Lymphocytic Leukemia Trial in Houston (Ibrutinib, Venetoclax)
Recruiting
- Chronic Lymphocytic Leukemia
- Ibrutinib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 21, 2022
Patients Undergoing Percutaneous Coronary Intervention
Recruiting
- Acute Coronary Syndrome
- +3 more
-
Jinan, Shandong, ChinaJinan Central Hospital
Jan 31, 2023
Parkinson's Disease, REM Sleep Behavior Disorder Trial in Montpellier (radiation, behavioral, other)
Terminated
- Parkinson's Disease
- REM Sleep Behavior Disorder
- FP-CIT single-photon emission computed tomography
- +2 more
-
Montpellier, FranceUniversity hospital
Dec 22, 2021
Gaucher Disease Type 1, Gaucher Disease Type 3 Trial in Worldwide (venglustat (GZ402671), imiglucerase)
Active, not recruiting
- Gaucher Disease Type 1
- Gaucher Disease Type 3
- venglustat (GZ402671)
- imiglucerase
-
New Haven, Connecticut
- +6 more
Aug 9, 2022
Substance-Related Disorders, Depression, Stress Disorders, Post-Traumatic Trial in Claremont, Lebanon (Wraparound)
Recruiting
- Substance-Related Disorders
- +4 more
- Wraparound
-
Claremont, New Hampshire
- +3 more
Jul 29, 2021
Diabetes Trial in Vienna, Paris (68Ga-NODAGA-exendin-4 PET/CT)
Recruiting
- Diabetes Mellitus
- 68Ga-NODAGA-exendin-4 PET/CT
-
Vienna, Austria
- +1 more
Jun 16, 2022
Neoadjuvant Immunochemotherapy for Lung Cancer
Completed
- Lung Cancer
- Neoadjuvant immunochemotherapy
-
Shanghai, Shanghai, ChinaZhencong Chen
Sep 1, 2023
Acute Myocardial Infarction, Dyslipidemias Trial in Aswan (Ezetimibe 10mg)
Recruiting
- Acute Myocardial Infarction
- Dyslipidemias
- Ezetimibe 10mg
-
Aswan, EgyptAswan Heart Centre
Jul 27, 2021